Newwill Biotech Pvt Ltd has a subsidiary for Research and Development called Nuwill Research and Innovations Private Limited (NRIPL) in Bangalore. This is a company which develops formulations to all global clients and markets. NRIPL is developing formulations for Newwill Biotech Pvt Ltd to register and market in the USA, EUROPE, AUSTRALIA and Rest of the World (ROW) countries. The formulations are basically, Tablets, Capsules, Creams and Ointments, Liquids, Injections, Transdermal patches and nanotechnology based drug delivery formulations.
Currently, Newwill Biotech Pvt Ltd is developing formulations for Canadian and European clients. also preparing product dossiers for ROW markets. By 2020, Newwill Biotech Pvt Ltd will have products marketed in all Asian and some of the European countries.
